show by Northern blotting and immunocytochemistry In this instance, the molecular defect alone does not that CHOP is induced in oligodendrocytes from a PMD compromise UPR induction (Sato et al., 2000) but, conpatient harboring a splice site mutation that excludes ceivably, may sensitize neurons to other insults. exon 6 from PLP1 gene products. Finally, we directly We have investigated molecular pathogenesis of the demonstrate that CHOP modulates disease severity in leukodystrophy Pelizaeus-Merzbacher disease (PMD), rsh mice and normally serves to protect oligodendroa neurodegenerative disease causing diffuse hypomycytes from apoptosis. Together, these data provide elination of the central nervous system (CNS). PMD is compelling evidence that the UPR is relevant to pathogenesis in PMD, thereby attesting to the importance of this regulatory pathway in disease. More broadly, suppositions by others that mutant secretory pathway proteins cause disease in different cell types through activation of the UPR portends PMD as the first example of a novel class of disparate degenerative diseases that nevertheless arise from a common molecular mechanism.
Results
The UPR has been examined in yeast and cultured mammalian cells following induction by noxious stimuli such as tunicamycin to inhibit glycoprotein synthesis, thapsigargin to mobilize internal Ca 2ϩ stores and expression of mutant secretory pathway proteins that accumulate in the endoplasmic reticulum (ER). Currently, the UPR is known to be activated through posttranslational processing of three ER-resident proteins, the Ire1 and PERK receptor kinases and the membrane-tethered transcription factor ATF6. Figure 2A ). Furthermore, Atf3 expression leva per cell basis (we routinely obtain 50% transfection efficiency in 293T cells), and we obtain similar results els decrease earlier than Chop, from approximately P15. Previously, we demonstrated accumulation of mutant using COS-7 cells (data not shown). Thus, these data suggest that UPR activation is a graded response rather DM-20/PLP1 in the perinuclear region of msd and rsh mouse oligodendrocytes (Gow et al., 1998) . We interpret than an on/off switch.
To confirm the transfection data in Figure 1A , we culthese data in terms of protein misfolding, which suggests that a common molecular mechanism accounts tured oligodendrocyte progenitors from msd mouse brains and differentiated these cells to induce expresfor the phenotypes of these allelic mutants. In support of this notion, we find that both Chop and Atf3 are insion of Plp1 gene products. Primary transcripts from this gene are alternatively spliced in exon 3 to encode duced in spinal cords of rsh mice compared to littermates at P21 ( Figure 2B ) as well as in jp mice. Totwo protein isoforms, PLP1 (contains exon 3a and b) and DM-20 (contains only exon 3a). The smaller DMgether, these data reveal important similarities in pathogenesis for all three mouse mutants despite dis-20 protein lacks a 35 amino acid hydrophilic peptide (encoded by exon 3b) which is near the center of the tinct genetic lesions and disease severities in these animals. protein and is exposed to the cytoplasm (Gow et al., 1997). Remaining exons are present in both mRNAs.
Steady-state mRNA levels of three molecular chaperones in spinal cords of msd, rsh, and jp mice are shown Wild-type oligodendrocytes extend processes from the cell body and incorporate DM-20/PLP1 into the plasin Figure 2C . In msd mice, mRNAs for Bip, Erp59, and Erp72 are increased, particularly at P13, when the bemalemma (green, Figure 1Da ). These processes elaborate membrane sheets that are also DM-20/PLP1 posihavioral phenotype becomes apparent. In similar fashion, jp and rsh mice exhibit roughly 2-fold increases in tive. The arrowhead points to the nucleus, which is not labeled by anti-CHOP antibodies. However, nuclei of the levels of molecular chaperones, which again points to activation of the UPR. Previously, we reported expres-DM-20/PLP1-positive oligodendrocytes from msd mice are robustly CHOP positive, which appears yellow (arsion of six molecular chaperones induced to varying extents in msd and jp mice, which implies broad inducrowhead, Figure 1Db is at an advanced stage in many CNS regions (Gow et al., 1998) . Few oligodendrocytes remain in cerebellar Indeed, Docs1 and 6 are not detected, and Doc4 mRNA levels actually decrease in the mutants. By nonquantitawhite matter, and DM-20/PLP1 staining is principally localized to perinuclear regions of these cells (inset, tive RT-PCR, we detect Doc4 and Doc6 but not Doc1 mRNAs, indicating that this latter gene, at least, is not Figures 3D and 3F ). Many oligodendrocytes in the cerebellum express CHOP at high levels, and, most impora target of CHOP in the CNS ( Figure 2F) . Quantification of Doc4 levels by ribonuclease protectantly, this protein is nuclear localized (inset, Figures 3E and 3F). Expression and nuclear localization of CHOP tion assays indicate that expression is decreased to 57% of wild-type levels, using ␤-actin as an internal in rsh oligodendrocytes is similar to that in msd mice (inset, Figures 3H and 3I) . Thus, together with our previcontrol ( Figure 2G Oligodendrocytes are widely known to be localized calization for ATF3 and S100␤ (astrocytes) and Ͻ1% for ATF3 and Mac-1 (macrophages) or ATF3 and CD3⑀ (T to white matter tracts (WM); however, these cells also reside in gray matter (GM), as reflected in Northern blots cells). Thus, the major cell populations that express ATF3 in CNS of rsh and msd mice are oligodendrocytes of patient tissue probed with human PLP1 cDNA ( Figure  6B ). In an MS patient, CHOP is expressed at comparable and microglia. steady-state levels in gray and nonplaque white matter regions. Gray matter is largely comprised of neuronal The UPR Is Induced Specifically in White Matter of a PMD Patient cell bodies, while white matter is rich with glial cells; thus, different cell types in apparently normal tissue To determine the relevance to PMD of our conclusions from previous (Gow et al., 1994b, 1998; Gow and Lazzaexpress CHOP at low but comparable levels. In contrast, we observe a 5-fold increase in CHOP between white rini, 1996; Southwood and Gow, 2001) and current analyses, we examined expression of UPR effector genes in and gray matter from the ⌬exon6 patient, indicating that this gene is selectively induced in the glial cell populaautopsy specimens from a patient with multiple sclerosis (MS) and a PMD patient with severe disease caused tion. Furthermore, ATF3, BIP, ERp59, and ERp72 are selectively induced in white matter from this patient. by a splice site mutation in intron 6 of the PLP1 gene that causes an in-frame deletion of the 66 base pair Thus, these data are consistent with our findings in vitro and in animal models demonstrating activation of the exon 6 (⌬exon6) in mRNAs from cultured skin fibroblasts antibodies. Together, these data provide direct evidence for a pivbe related to the cell type-specific target genes of this transcription factor. Nevertheless, available data conotal role of CHOP in pathogenesis and demonstrate vincingly indicates that CHOP is a key regulatory comthat the activity of this transcription factor serves to ponent of the UPR in kidney cells and oligodendrocytes. ameliorate the toxic effects of mutant DM-20/PLP1 in Additional diversity in cell type-specific functions of oligodendrocytes.
Chop is (Figure 7) . These data reveal a major divergence ATF3 in oligodendrocytes from these mutants. Furtherin importance of CHOP as a central mediator of cell more, expression of these transcription factors is not induced in white matter from a PMD patient harboring death for different cell types which, conceivably, could of misfolded protein in this organelle (Gow and Lazzarini, 1996) . Finally, we show in Figure 1C that, on a per PLP1 may be particularly toxic to cells. we anticipate a UPR associated with the latter but not Recent appreciation of the UPR has led to speculation the former genetic form of PMD. However, perhaps the that disrupting or overwhelming this signaling cascade strongest evidence of a distinct pathogenic mechanism might play a role in pathogenesis for a number of degenfor Plp1 overexpression is revealed by a recent study erative diseases (Aridor and Balch, 1999). Herein, we showing inappropriate targeting to lysosomes of cholesshow that PLP1 mutations induce the UPR and that terol and lipid raft components, which are normally disruption of this pathway dramatically increases dissorted to the Golgi (Simons et al., 2002) . ease severity. Thus, PMD is the first example of a degenConsistent with variable disease severity observed for erative disease where the UPR modulates pathogenesis. different PLP1 coding region mutations, we speculate In the search for additional UPR-linked diseases, it is that upstream elements of the UPR confer a graded important to develop criteria that exclude diseases arisresponse to metabolic stress: the greater the accumulaing from other pathogenic mechanisms. In this vein, null tion, the more intense the UPR and the higher the likelialleles should confer a phenotype that is significantly hood of apoptosis. Several studies support this model. more mild than or clinically distinct from at least some For example, we previously described a cellular mechacoding region mutations. This criterion rules out mutanism that accounts for disease severity in PMD on the tions that simply abolish protein function. This is the basis of the amount of PLP1 gene products accumulatcase for PLP1 and for ␣ 1 -ANTITRYPSIN, where null muing in the ER (Gow and Lazzarini, 1996) . The interpretatations cause emphysema and missense mutations action from these data and additional mutations (A.G., cumulating in the ER cause hepatitis (Dycaico et al., unpublished data) is illustrated in Figure 8A . Thus, eight 1988). missense mutations causing ER accumulation of both A second distinguishing feature of UPR-linked dis-DM-20 and PLP1 (including msd) give rise to severe eases is dominant or semidominant inheritance, at least disease (Figure 8Aa ). In contrast, nine mutations that at the level of individual cells. PMD is technically a recesdisrupt trafficking to the cell surface of PLP1 but not sive disease, because PLP1 is located on the X chromo-DM-20 (including rsh) cause mild disease (Figure 8Ab) . some, and carrier females rarely develop symptoms. Furthermore, wild-type or mutant forms of DM-20 that However, mutant PLP1 gene products act dominantly traverse the secretory pathway can transport mutant because the jp phenotype cannot be rescued with a wild-type Plp1 transgene (Schneider et al., 1995) . Addi-PLP1 out of the ER, which, presumably, reduces levels
